Search

everythinglearnresearchcommunity

for

Search:↓

The study found that a one-step antibody method is better than the LSAB method for accurately studying hair follicle structures without false positives.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Inhibiting retinoic acid activates WNT signaling, potentially aiding hair disorder and skin cancer treatments.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

Patients with thyroid disorders show different symptoms and antibody levels.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

Washing can prevent cancer from lubricating oils, extreme body temperatures need more study, Sulfomid is not recognized, no reliable diphtheria carrier treatment except surgery, eyelid injuries should heal before repair, heterophile antibody test is specific for mononucleosis, chlorine inhalations for colds are outdated, and wheat germ is safe.

Fos protein is crucial for cell transition to cornification in keratinized tissues.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Mast cells and the CB1 receptor may be key in causing IgA vasculitis.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

The research found a way to identify and study skin cells with stem cell traits, revealing they behave differently in culture and questioning current stemness assessment methods.

Merkel cell increase is specific to certain skin diseases, not general skin growth.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Ocrelizumab may cause pancreatitis in some patients.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.